A new centralised procurement framework from China is set to heighten pricing and competitive pressure for device makers, says BMI, which expects the policy to favour manufacturers with competitive prices and strong service networks.
This is despite pricing pressures and domestic competition. China’s medical device market will reach $48.1b by 2030, driven by an ageing population, chronic diseases, increased hospital investment and demand for advanced medical technologies. According to a BMI report, the market is set to sustain its growth despite procurement-driven pricing pressures and domestic competition.
“China’s July 2026 framework for centralised medical equipment procurement will heighten pricing and competitive pressures,” the report said. Whilst lifecycle costs, quality and service will gain importance in…
Read the full report on Healthcare Asia Magazine
Story file
- Section
- Health
- First reported by
- Healthcare Asia Magazine
- Reporter
- staff reporter
- Published
- Wednesday, 14 October 2026, 2:30 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Healthcare Asia Magazine with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
